FDG PET联合心脏MRI用于心脏结节病的诊断与治疗监测评估
回顾性纳入80例疑似心脏结节病的结节病患者,比较FDG PET与CMR的诊断一致性及治疗监测价值。治疗中PET表现全部改善(7/7),而LGE仅33%改善(3/9)。
要点
- 治疗中PET表现全部改善(7/7),LGE仅33%(3/9)改善。
核心结论
- 由于假阳性或不确定结果风险高,PET可作为LGE病例的二线检查以评估炎症负荷;PET似乎适合预测和评估治疗反应。
研究设计与样本
- 回顾性纳入80例疑似心脏结节病的结节病患者,均行FDG PET和CMR;PET采用低糖高脂饮食后16排PET/CT相机采集;50例(50/80)在治疗中监测并分为应答者与非应答者。
关键影像表现/征象
- PET阳性定义为局灶或多灶性FDG摄取。
- CMR阳性定义为心外膜下延迟钆增强(LGE)。
诊断标准与关键数值
- PET阳性标准为局灶或多灶性FDG摄取。
- CMR阳性标准为心外膜下LGE。
临床应用与阅片要点
- 基线PET阳性者临床应答较基线PET阴性者更常见(80% vs 45%,p=0.07)。
- 治疗中PET表现全部改善(7/7),而LGE仅33%(3/9)改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To compare combined 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron-emission tomography (PET) and cardiac magnetic resonance imaging (CMR) for the diagnosis and therapy monitoring of cardiac sarcoidosis (CS).
MATERIALS AND METHODS: Eighty patients with sarcoidosis and a suspicion of CS who underwent PET and CMR were included retrospectively. PET was undertaken after a low-carbohydrate-high-fat diet in all patients using a combined 16-section PET/computed tomography (CT) camera. PET was considered positive (PET+) in cases of focal or multifocal FDG uptake. CMR was considered positive (CMR+) in cases of subepicardial late gadolinium enhancement (LGE). A subgroup of 50 patients (50/80) was monitored during therapy and classified as responders or non-responders.
RESULTS: Eighty-two percent of patients with PET+ (9/11) also had CMR+ imaging, with good spatial agreement (kappa=0,79; 95% confidence interval [CI]: 0.65-0.94). Twenty-seven percent (22/80) had residual physiological FDG uptake, with a standardised uptake value (SUV) not significantly different compared to the SUV from pathological uptake (6.4 versus 6 respectively, p=0,92). The clinical response was more frequent in patients with baseline PET+ compared to baseline PET- (80% versus 45%, p=0.07). PET findings improved in all cases under treatment (7/7), whereas LGE improved in only 33% of patients (3/9).
CONCLUSION: Due to high risk of false-positive or undetermined findings, PET might be performed as a second-line study in cases of LGE, to assess inflammatory load. In addition, PET seems suitable to predict and assess response under therapy.
引用
- Sgard B, Brillet PY, Bouvry D, et al. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis. Clin Radiol. 2018. PMID: 30482560. doi:10.1016/j.crad.2018.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。